TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8898763

Group type: EXPERIMENTAL
Intervention: Hypertension defined as systolic blood pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg or current use of antihypertensive medications
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Comparison with NHANES III
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Comparison with San Antonio Mexican Americans
Number of subjects: 1004
Study: 1892962

Group type: EXPERIMENTAL
Intervention: Alprazolam treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nonresponders to alprazolam
Number of subjects: 36

Group type: COMPARATOR
Intervention: Patients clinically unchanged with placebo
Number of subjects: 36
Study: 6325994

Group type: EXPERIMENTAL
Intervention: sotalol, 320 or 960 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 30476104

Group type: EXPERIMENTAL
Intervention: SEL-PLEX (organic forms of Se, OSe)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1:1 blend of ISe and OSe (MIX)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sodium selenite (inorganic Se, ISe)
Number of subjects: 24
Study: 29954199

Group type: EXPERIMENTAL
Intervention: Mobile-bearing TKA
Number of subjects: 240

Group type: COMPARATOR
Intervention: Fixed-bearing TKA (all-polyethylene and modular metal-backed)
Number of subjects: 240
Study: 26230332

Group type: EXPERIMENTAL
Intervention: Coadministration of lopinavir and amprenavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lopinavir alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amprenavir alone
Number of subjects: 0
Study: 22840353

Group type: EXPERIMENTAL
Intervention: Robot-assisted radical prostatectomy (RARP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nerve-sparing techniques in RARP
Number of subjects: 120

Group type: COMPARATOR
Intervention: Laparoscopic radical prostatectomy (LRP)
Number of subjects: 120
Study: 21857481

Group type: EXPERIMENTAL
Intervention: LC/LERV (N=45)
Number of subjects: 98

Group type: COMPARATOR
Intervention: LC/IOES (N=53)
Number of subjects: 98
Study: 19792989

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 or 25 mg/day for 9 weeks
Number of subjects: 202
Study: 17719559

Group type: EXPERIMENTAL
Intervention: Attention focusing
Number of subjects: 63

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 63
Study: 15475095

Group type: EXPERIMENTAL
Intervention: Administration of more than 3 l of crystalloids during abdominal surgery
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Administration of more than 500 ml of colloids during abdominal surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: Other studied factors
Number of subjects: 150
Study: 11345374

Group type: EXPERIMENTAL
Intervention: Side-by-side method
Number of subjects: 219

Group type: COMPARATOR
Intervention: Serial method
Number of subjects: 219
Study: 9605678

Group type: EXPERIMENTAL
Intervention: Doppler ultrasonography guidance
Number of subjects: 286

Group type: COMPARATOR
Intervention: Standard method
Number of subjects: 286
Study: 7742331

Group type: EXPERIMENTAL
Intervention: Recombinant hepatitis B vaccine 10 micrograms
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Recombinant hepatitis B vaccine 20 micrograms
Number of subjects: 100
Study: 1965288

Group type: EXPERIMENTAL
Intervention: Fluoride dentifrice (A.D.A.-accepted)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride dentifrices containing anticalculus agents (soluble pyrophosphates, zinc chloride, zinc oxide)
Number of subjects: 0
Study: 97033

Group type: EXPERIMENTAL
Intervention: 1 mg ketotifen taken orally for 3 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20 mg DSCG inhaled four times daily for 3 days
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ketotifen
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DSCG
Number of subjects: 10
Study: 31822848

Group type: EXPERIMENTAL
Intervention: Genomics ADvISER decision aid
Number of subjects: 133
Study: 28926349

Group type: EXPERIMENTAL
Intervention: Nurse-led care program plus routine hospital care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine hospital care
Number of subjects: 0
Study: 26436433

Group type: EXPERIMENTAL
Intervention: Traditional Thai Massage (TTM)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 29
Study: 22956679

Group type: EXPERIMENTAL
Intervention: intervention group (self-regulation)
Number of subjects: 851

Group type: COMPARATOR
Intervention: standard group (intention formation)
Number of subjects: 851
Study: 21613310

Group type: EXPERIMENTAL
Intervention: Mavrilimumab (0.01-10.0 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mavrilimumab (1.0 and 3.0 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Mavrilimumab (n=15 with baseline DAS28 >3.2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 20394133

Group type: EXPERIMENTAL
Intervention: Behavioral Contracting (Group 3)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Behavioral Contracting (Group 4)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control Group 1
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control Group 2
Number of subjects: 27
Study: 16958291

Group type: EXPERIMENTAL
Intervention: Tyrian SPE + One Step Plus applied according to manufacturer's recommendation (2 coats of adhesive)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tyrian SPE + One Step Plus (4 coats of adhesive)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Phosphoric acid + One Step Plus applied according to manufacturer's recommendation (2 coats of adhesive)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Phosphoric acid + One Step Plus (4 coats of adhesive)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 29
Study: 15193480

Group type: EXPERIMENTAL
Intervention: Combined treatment of l-carnitine (2 g/d) and l-acetyl-carnitine (1 g/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10958260

Group type: EXPERIMENTAL
Intervention: Antidepressants (imipramine, clomipramine, paroxetine)
Number of subjects: 326
Study: 9373765

Group type: EXPERIMENTAL
Intervention: ET-1 infusion (0.4 pmol kg-1 min-1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1373485

Group type: EXPERIMENTAL
Intervention: 89Sr-strontium chloride (0 MBq, n=21; 37 MBq, n=65; 75 MBq, n=72; 100 MBq, n=25; 150 MBq, n=17)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 89Sr-strontium chloride
Number of subjects: 200
Study: 4076305

Group type: EXPERIMENTAL
Intervention: Diazepam 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nondrug conditions in patients with primary degenerative dementia
Number of subjects: 0
Study: 30833486

Group type: EXPERIMENTAL
Intervention: Miracle Mouthwash (MMW)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prednisolone (P)
Number of subjects: 100
Study: 30424775

Group type: EXPERIMENTAL
Intervention: Household ownership of LLINs
Number of subjects: 5196

Group type: EXPERIMENTAL
Intervention: Adequate LLIN coverage
Number of subjects: 5196

Group type: EXPERIMENTAL
Intervention: Use of LLINs
Number of subjects: 5196
Study: 29952189

Group type: EXPERIMENTAL
Intervention: PLF with local bone graft with BM concentrate augmentation (BM group)
Number of subjects: 12

Group type: COMPARATOR
Intervention: PLF with local bone graft only (non‐BM group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BM group
Number of subjects: 12

Group type: COMPARATOR
Intervention: non‐BM group
Number of subjects: 12
Study: 25244442

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg/day
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 22714033

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin (100 mg suppository)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo (inert suppository)
Number of subjects: 228
Study: 20662716

Group type: EXPERIMENTAL
Intervention: Replication-defective adenovirus type 5 HIV-1 gag vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16870842

Group type: EXPERIMENTAL
Intervention: Inspiratory threshold loading
Number of subjects: 6
Study: 16244523

Group type: EXPERIMENTAL
Intervention: 6 degrees lateral wedge
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0 degrees control wedge
Number of subjects: 50
Study: 12172314

Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 66

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Nurse-recorded BP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 24-h ambulatory BP
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Normal ambulatory BP
Number of subjects: 66
Study: 9549819

Group type: EXPERIMENTAL
Intervention: Palliative treatment in advanced cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imputation of missing QOL data based on auxiliary outcome variables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventative strategies in trial design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collection of auxiliary QOL information
Number of subjects: 0
Study: 7605708

Group type: EXPERIMENTAL
Intervention: Weight-bearing exercise (50 'heel drops' daily and weekly mixed exercise class)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (weekly low-impact exercise class and daily flexibility exercises)
Number of subjects: 44
Study: 2178854

Group type: COMPARATOR
Intervention: 150 mg ranitidine (single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 150 mg ranitidine (multiple doses, b.i.d. for 7 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ranitidine (7 days treatment)
Number of subjects: 12
Study: 6994824

Group type: EXPERIMENTAL
Intervention: Frontal EMG biofeedback and progressive relaxation training for 15 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 31577041

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) gel treatment for 45 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no HA treatment)
Number of subjects: 54
Study: 30741701

Group type: EXPERIMENTAL
Intervention: Training serial button-press motor task (SPMT), 5 days a week for two consecutive weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 20
Study: 28673527

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Assessment Only (AO)
Number of subjects: 530
Study: 23294942

Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 1000
Study: 23604998

Group type: EXPERIMENTAL
Intervention: High-load resistance exercise (n=22)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Low-load resistance exercise (n=21)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care (n=19)
Number of subjects: 62
Study: 21819517

Group type: EXPERIMENTAL
Intervention: Insulin lispro protamine suspension (ILPS)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 383
Study: 19683429

Group type: EXPERIMENTAL
Intervention: Ixabepilone
Number of subjects: 0
Study: 17881751

Group type: EXPERIMENTAL
Intervention: Repeat courses of antenatal corticosteroids (betamethasone, 12 mg intramuscularly, repeated once at 24 hours)
Number of subjects: 556

Group type: COMPARATOR
Intervention: Placebo (identical-appearing)
Number of subjects: 556

Group type: EXPERIMENTAL
Intervention: Repeat courses of antenatal corticosteroids
Number of subjects: 556

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study: 15089812

Group type: EXPERIMENTAL
Intervention: St John's wort
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ginseng
Number of subjects: 12

Group type: COMPARATOR
Intervention: Warfarin alone
Number of subjects: 12
Study: 11347790

Group type: EXPERIMENTAL
Intervention: Training intervention (14-hour program in seven weekly 2-hour sessions)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Training intervention
Number of subjects: 94

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 94
Study: 9783563

Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine (starting at 25 mg/d and increasing to 250 mg/d)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine (initially randomized to i.v. clomipramine and treated subsequently with oral clomipramine)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intravenous placebo (initially randomized to receive i.v. placebo and treated subsequently with several days of open-label i.v. clomipramine)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intravenous clomipramine (1 month after i.v. infusion)
Number of subjects: 54
Study: 7945519

Group type: EXPERIMENTAL
Intervention: Ibuprofen lysinate (IBL) 800 mg/d
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 2000 mg/d
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 3604740

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxazepam
Number of subjects: 60
Study: 29258336

Group type: EXPERIMENTAL
Intervention: Chickpea-based RUTF
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rice-lentil-based RUTF
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prototype RUTF (Plumpy'Nut)
Number of subjects: 30
Study: 28215117

Group type: EXPERIMENTAL
Intervention: Parental stretching program
Number of subjects: 94

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 94
Study: 26323772

Group type: EXPERIMENTAL
Intervention: Bench step exercise for 16 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 13
Study: 23914766

Group type: EXPERIMENTAL
Intervention: Compassion induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral induction
Number of subjects: 0
Study: 20940102

Group type: COMPARATOR
Intervention: Whole Body Vibration (WBV)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Maximal Voluntary Contractions (MVC)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MVC alternated with WBV (MVC-WBV)
Number of subjects: 9
Study: 19317165

Group type: EXPERIMENTAL
Intervention: Bushen Tongdu Decoction (BTD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Azulfidine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal control (30 healthy persons)
Number of subjects: 75
Study: 16015665

Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride (CH) 4 mg up to four times a day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride (CH) continued from the short-term study
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (original short-term study)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride (CH)
Number of subjects: 12
Study: 12937950

Group type: EXPERIMENTAL
Intervention: Image fusion between FDG-PET and CT
Number of subjects: 32
Study: 10383550

Group type: EXPERIMENTAL
Intervention: Bosentan 500 mg twice daily for 1 week
Number of subjects: 18

Group type: COMPARATOR
Intervention: Digoxin 0.375 mg once daily for 13 days
Number of subjects: 18
Study: 8720227

Group type: EXPERIMENTAL
Intervention: Stop-steroid group (19 patients)
Number of subjects: 89

Group type: COMPARATOR
Intervention: No-steroid group (70 patients)
Number of subjects: 89
Study: 1879030

Group type: EXPERIMENTAL
Intervention: Tablet cucumber vine compound
Number of subjects: 389

Group type: COMPARATOR
Intervention: Tablet hypotension compound (Control)
Number of subjects: 389
Study: 7106164

Group type: EXPERIMENTAL
Intervention: Indapamide 5.0 mg solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indapamide 2.5 mg tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 0
Study: 31927028

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 31083767

Group type: EXPERIMENTAL
Intervention: Smoke Free smartphone application
Number of subjects: 4990

Group type: COMPARATOR
Intervention: No support (control)
Number of subjects: 4990
Study: 27662113

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1.5 mA)
Number of subjects: 37
Study: 26503370

Group type: EXPERIMENTAL
Intervention: New training model
Number of subjects: 77

Group type: COMPARATOR
Intervention: Old training model
Number of subjects: 77
Study: 23317171

Group type: EXPERIMENTAL
Intervention: Vitamin B12 deficiency patients
Number of subjects: 45

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 45
Study: 21598183

Group type: EXPERIMENTAL
Intervention: Water clubs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water and control clubs
Number of subjects: 0
Study: 19540518

Group type: EXPERIMENTAL
Intervention: Metoclopramide, 0.2 mg/kg/dose q 6 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Ranitidine, 2 mg/kg/dose q 8 hours
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 18
Study: 17296386

Group type: EXPERIMENTAL
Intervention: Video endoscopic inguinal lymphadenectomy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard inguinal lymphadenectomy
Number of subjects: 10
Study: 15385355

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg of rocuronium based on real body weight (Group 1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg of rocuronium based on ideal body weight (Group 2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rocuronium dosed based on real body weight in normal-weight female patients (Control group)
Number of subjects: 12
Study: 11481696

Group type: EXPERIMENTAL
Intervention: Idazoxan 20 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9755345

Group type: EXPERIMENTAL
Intervention: diet‐plus‐exercise program
Number of subjects: 177

Group type: COMPARATOR
Intervention: diet‐only program
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: diet‐plus‐exercise program (dissatisfied participants)
Number of subjects: 177
Study: 8110564

Group type: COMPARATOR
Intervention: i.v. fluids (preloading with normal saline 16 ml kg‐1 and, if necessary, three subsequent boluses of 2.5 ml kg‐1)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Metaraminol infusion titrated between 0 and 5 mg h‐1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ephedrine infusion titrated between 0 and 120 mg h‐1
Number of subjects: 34
Study: 3288007

Group type: EXPERIMENTAL
Intervention: Lidocaine aerosol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo aerosol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 30
Study: 30425166

Group type: EXPERIMENTAL
Intervention: Volumetric cough mode (VCM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Breath-stacking
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 20
Study: 28784453

Group type: EXPERIMENTAL
Intervention: Myocardial perfusion scintigraphy (MPS)
Number of subjects: 400
Study: 25034199

Group type: EXPERIMENTAL
Intervention: Plain Language Summary (PLS)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Current format used in Cochrane systematic reviews (Control)
Number of subjects: 143
Study: 22732767

Group type: COMPARATOR
Intervention: lumiracoxib
Number of subjects: 6
Study: 21906457

Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ondansetron (4 mg)
Number of subjects: 200
Study: 19106862

Group type: EXPERIMENTAL
Intervention: Pneumatic dilatation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic Heller cardiomyotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended esophageal myotomy
Number of subjects: 0
Study: 17238677

Group type: EXPERIMENTAL
Intervention: Electronic alert
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no electronic alert)
Number of subjects: 0
Study: 14983966

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening with prostate-specific antigen (PSA)
Number of subjects: 0
Study: 11186221

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8694322

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% (40 mL)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%, 40 mL)
Number of subjects: 41
Study: 1348167

Group type: EXPERIMENTAL
Intervention: Atracurium repeated injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atracurium infusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vecuronium repeated injection
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vecuronium infusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neostigmine (7 micrograms/kg)
Number of subjects: 40
Study: 4003624

Group type: EXPERIMENTAL
Intervention: BSE group education session
Number of subjects: 0
Study: 31939368

Group type: EXPERIMENTAL
Intervention: Mtwo files
Number of subjects: 30

Group type: COMPARATOR
Intervention: H‐files
Number of subjects: 30
Study: 28329315

Group type: EXPERIMENTAL
Intervention: Macitentan
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 28391664

Group type: EXPERIMENTAL
Intervention: Green tea extract tablets (0.7 g, 0.05% green tea extract, equivalent to 1 mg polyphenols for three tablets)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo tablets (identical to test tablets but without active agent)
Number of subjects: 54
Study: 24628987

Group type: EXPERIMENTAL
Intervention: Limited ablation (CFAE: <60 milliseconds)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Extensive ablation (CFAE: <120 milliseconds)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both limited and extensive approaches
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Limited ablation
Number of subjects: 90
Study: 20924095

Group type: EXPERIMENTAL
Intervention: Clinical pharmacy service (CPS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual medical care (control)
Number of subjects: 300
Study: 20108208

Group type: EXPERIMENTAL
Intervention: Diet C (increased consumption of cereals, some enriched with vitamin D)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Diet V (increased consumption of greens and vegetables)
Number of subjects: 61